Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chittaranjan Behera

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacy and Pharmacology|September 1, 2021
Mechanistic investigation of synergistic interaction of tocopherol succinate with a quinoline-based inhibitor of mammalian target of rapamycinChittaranjan Behera, Jaspreet Kour, Nagma Banjare, et al.
International Journal of Pharmaceutics|November 22, 2023
Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cellsChittaranjan Behera, Kamalpreet Kaur Sandha, Nagma Banjare, et al.
International Journal of Biological Macromolecules|September 11, 2022
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer modelVikas, Abhishesh Kumar Mehata, M Nikitha Lakshmi Suseela, et al.
International Journal of Biological Macromolecules|January 4, 2025
Retraction notice to "Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model" [Int. J. Biol. Macromol. 221 (2022) 874-890]Vikas, Abhishesh Kumar Mehata, M Nikitha Lakshmi Suseela, et al.
European Journal of Medicinal Chemistry|September 18, 2020
Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agentsDivya Dheer, Chittaranjan Behera, Davinder Singh, et al.
Molecular Pharmaceutics|May 17, 2023
Antifibrotic Agent Mediated Tumor Microenvironment Modulation and Improved Nanomedicine Delivery in Solid TumorKamalpreet Kaur Sandha, Chittaranjan Behera, Pankaj Chibber, et al.
Molecular Pharmaceutics|May 31, 2022
Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer TherapyAkanksha Behl, Parul Sarwalia, Sushil Kumar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 17, 2022
Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacyChittaranjan Behera, Kamalpreet Kaur Sandha, Nagma Banjare, et al.
Journal of Forensic and Legal Medicine|November 19, 2019
Biochemical findings in sudden unexpected death in epilepsy: Hospital based case-control studyShyam Kishore, Sudhir Kumar Gupta, Sudheer Kumar Arava, et al.
ACS Applied Bio Materials|January 16, 2023
Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and <i>In Vitro</i> Immunosuppressive ActivityDavinder Singh, Irfan Qasam, Gourav Paudwal, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacy and Pharmacology|September 1, 2021
Mechanistic investigation of synergistic interaction of tocopherol succinate with a quinoline-based inhibitor of mammalian target of rapamycinChittaranjan Behera, Jaspreet Kour, Nagma Banjare, et al.
International Journal of Pharmaceutics|November 22, 2023
Biodegradable nanocarrier of gemcitabine and tocopherol succinate synergistically ameliorates anti-proliferative response in MIA PaCa-2 cellsChittaranjan Behera, Kamalpreet Kaur Sandha, Nagma Banjare, et al.
International Journal of Biological Macromolecules|September 11, 2022
Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer modelVikas, Abhishesh Kumar Mehata, M Nikitha Lakshmi Suseela, et al.
International Journal of Biological Macromolecules|January 4, 2025
Retraction notice to "Chitosan-alginate nanoparticles of cabazitaxel: Design, dual-receptor targeting and efficacy in lung cancer model" [Int. J. Biol. Macromol. 221 (2022) 874-890]Vikas, Abhishesh Kumar Mehata, M Nikitha Lakshmi Suseela, et al.
European Journal of Medicinal Chemistry|September 18, 2020
Design, synthesis and comparative analysis of triphenyl-1,2,3-triazoles as anti-proliferative agentsDivya Dheer, Chittaranjan Behera, Davinder Singh, et al.
Molecular Pharmaceutics|May 17, 2023
Antifibrotic Agent Mediated Tumor Microenvironment Modulation and Improved Nanomedicine Delivery in Solid TumorKamalpreet Kaur Sandha, Chittaranjan Behera, Pankaj Chibber, et al.
Molecular Pharmaceutics|May 31, 2022
Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer TherapyAkanksha Behl, Parul Sarwalia, Sushil Kumar, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 17, 2022
Implication of methylselenocysteine in combination chemotherapy with gemcitabine for improved anticancer efficacyChittaranjan Behera, Kamalpreet Kaur Sandha, Nagma Banjare, et al.
Journal of Forensic and Legal Medicine|November 19, 2019
Biochemical findings in sudden unexpected death in epilepsy: Hospital based case-control studyShyam Kishore, Sudhir Kumar Gupta, Sudheer Kumar Arava, et al.
ACS Applied Bio Materials|January 16, 2023
Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and <i>In Vitro</i> Immunosuppressive ActivityDavinder Singh, Irfan Qasam, Gourav Paudwal, et al.
Pageof 8